APOA5 Variant rs662799, Role in Cardiovascular Traits and Serum Adipokine Levels in Caucasian Obese Subjects
Authors:
- 2 July 2021
- journal article
- research article
- Published by S. Karger AG in Annals of Nutrition and Metabolism
- Vol. 77 (5) , 299-306
Abstract
Background and Aims: This ApoA5-1131C allele of rs662799 variant is related with a higher serum triglyceride levels, and it contributes to increase risk of cardiovascular disease. The aim of the present investigation was to evaluate single nucleotide polymorphism rs662799 in APOA5 gene and its associations with cardiovascular risk factors, MS, and serum adipokine levels. Methods: The study involved a population of 1,002 Caucasian obese subjects. Measurements of body weight, waist circumference, fat mass, arterial blood pressure, blood glucose, C-reactive protein, insulin levels, insulin resistance (HOMA-IR), lipid profile, and adipokines levels were recorded. Genotype of ApoA5 gene polymorphism (rs662799) and prevalence of metabolic syndrome (MS) were evaluated. Results: The distribution of the rs662799 polymorphism in this adult population (n = 1,002) was 88.3% (n = 885) (TT), 11.4% (n = 114) (TC), and 0.3% (n = 3) (CC). No significant differences were found between the 2 genotypes in the anthropometric data, MS, or blood pressure. Triglyceride levels were higher in C-allele carriers (delta total group: 19.7 ± 2.1 mg/dL: p = 0.02) than non C-allele carriers. HDL-cholesterol levels were lower in C-allele carriers (delta total group: −6.7 ± 1.1 mg/dL: p = 0.02) than non C-allele carriers. Adiponectin levels were lower in C-allele carriers (delta total group: −11.6 ± 1.0 mg/dL: p = 0.02) too. In C-allele carriers, logistic regression analysis showed an increased risk of hypertriglyceridemia (odds ratio [OR] = 2.1, 95% confidence interval [CI] = 1.2–3.4, p = 0.001) and percentage of low-HDL-C (OR = 2.2, 95% CI = 1.3–3.7, p = 0.002) after adjusting by body mass index and age. Conclusions: C-allele carriers of rs662799 of APOA5 gene showed high rates of low levels of HDL and hypertriglyceridemia, with differences in triglyceride, HDL cholesterol, and adiponectin levels in Caucasian obese subjects.Keywords
This publication has 34 references indexed in Scilit:
- Association of Apolipoprotein A5 Gene1131TC Polymorphism with the Risk of Metabolic Syndrome in Korean SubjectsBioMed Research International, 2013
- Association between glucokinase regulatory protein (GCKR) and apolipoprotein A5 (APOA5) gene polymorphisms and triacylglycerol concentrations in fasting, postprandial, and fenofibrate-treated statesThe American Journal of Clinical Nutrition, 2009
- Adiponectin and its association with insulin resistance and type 2 diabetesJournal of Genetics and Genomics, 2008
- Apolipoprotein A-V, triglycerides and risk of coronary artery disease: the prospective Epic-Norfolk Population StudyJournal of Lipid Research, 2006
- Genetic analysis of APOAV polymorphisms (T-1131/C, Ser19/Trp and Val153/Met): no effect on plasma remnant particles concentrationsClinica Chimica Acta, 2004
- Endocrine Regulation of Energy Metabolism: Review of Pathobiochemical and Clinical Chemical Aspects of Leptin, Ghrelin, Adiponectin, and ResistinClinical Chemistry, 2004
- APOA5 gene polymorphism modulates levels of triglyceride, HDL cholesterol and FERHDL but is not a risk factor for coronary artery diseaseAtherosclerosis, 2004
- Implications of plasma concentrations of adiponectin in patients with coronary artery diseaseHeart, 2004
- Evaluation of an Enzyme Immunometric Assay to Measure Serum Adiponectin ConcentrationsClinical Chemistry, 2004
- Association of postprandial hypertriglyceridemia and carotid intima-media thickness in patients with type 2 diabetes.Diabetes Care, 2000